Citation tools
"The First Clinical Use of a Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E7 Oncogene Oral Vaccine: A Phase I Safety and Immunogenicity Trial in Healthy Women Volunteers." Molecular Cancer Therapeutics
19.2
(2020):
717-727.
Web. 05 Mar. 2021.